Your Location：
Home >
Browse articles >
Establishment and Implementation of Post-marketing Benefit-risk Assessment Strategy for Traditional Chinese Medicine
Updated：2025-08-21
Previous|Next

    • Establishment and Implementation of Post-marketing Benefit-risk Assessment Strategy for Traditional Chinese Medicine

      Enhanced Publication
    • QIAO Meng , PENG Wenxi , ZHANG Qiang , LEI Chao , XIE Yanming , WANG Zhifei
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 18, Pages: 253-260(2025)

    • DOI： 10.13422/j.cnki.syfjx.20251467     

      CLC：

    • Revised：2025-03-09 ，

      Accepted：13 March 2025 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 2 )

  • References

  • Publication Info

  • Metrics

298

Views

329

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Clinical Comprehensive Evaluation of Changyanning Granules in Treatment of Diarrhea（Damp-heat Syndrome）
Comprehensive Clinical Evaluation of Xiaojie'an Capsules in Treatment of Uterine Fibroids with Qi Stagnation and Blood Stasis Syndrome
Clinical Comprehensive Evaluation of Guanxinjing Capsules in Treating Angina Pectoris of Coronary Heart Disease with Syndrome of Qi Deficiency and Blood Stasis in "6+1" Dimensions
Clinical Comprehensive Evaluation of Zhichuanling Oral Liquid in Treatment of Asthma and Considerations for Cultivating High-value Patents
Cloning and Functional Characterization of O-Methyltransferase Gene in Carthamus tinctorius

Related Author

XIE Yanming
LU Zhenkai
WANG Xiaoyan
MA Yutong
MA Yutong
WANG Lianxin
LYU Jian
CUI Xin

Related Institution

Xiyuan Hospital， China Academy of Chinese Medical Sciences
Institute of Information on Traditional Chinese Medicine， China Academy of Chinese Medical Sciences
Institute of Basic ResearchMedicine，China Academy of Chinese Medical Sciences
Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
Institute of Basic Research in Clinical Medicine， China Academy of Chinese Medical Sciences